TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details January 7, 1983
TCL Archive Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals April 18, 1986
